Jumonji Domain Containing 6 (JMJD6) Peptide
JMJD6
Reactivity: Human
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN982411
Quick Overview for Jumonji Domain Containing 6 (JMJD6) Peptide (ABIN982411)
Target
JMJD6
(Jumonji Domain Containing 6 (JMJD6))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PTDSR antibody (Catalog #: ARP31807_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- JMJD6 (Jumonji Domain Containing 6 (JMJD6))
-
Background
-
PTDSR is required during embryogenesis and differentiation of multiple organs during embryogenesis. PTDSR probably acts as a key regulator of hematopoietic differentiation. PTDSR may not be required for apoptotic cell clearance by macrophages but seems to be necessary for the regulation of macrophage cytokine responses
Alias Symbols: PSR, PTDSR, PTDSR1
Protein Interaction Partner: DOCK1,ELMO1
Protein Size: 372 -
Molecular Weight
- 43 kDa
-
Gene ID
- 23210
-
NCBI Accession
- NM_015167, NP_055982
Target
-
You are here:
